НовостиBenzingaBTIG Maintains Buy on Caris Life Sciences, Raises Price Target to $38 BTIG Maintains Buy on Caris Life Sciences, Raises Price Target to $38 Benzinga 2026.10.27 16:50 (GMT+0) Открыть на Benzinga Другие новости